Study characteristics | |||
Patient sampling | Retro‐ or prospective enrolment not known | ||
Patient characteristics and setting | Sample size: 87 patients Mean age: 58 years (range 19‐79) Presentation: Patients with primary ovarian cancer FIGO Stage IIIC/IV, good nutrition status, WHO < 2, no contraindications for surgery, evaluation for optimal primary debulking surgery (RT = 0) Diagnostics before index test: physical/gynaecological examination, ultrasonography, CA 125, CT abdomen/pelvis, Thorax x‐ray/CT Kind of surgery: PDS 53; IDS 25: No debulking surgery: 9 Setting: Department of gynaecology, University hospital Rome, Italy |
||
Index tests | Open diagnostic laparoscopy; examination of the whole abdominal cavity, biopsies for frozen section, performed by gynaecological oncologist. If judged resectable direct cytoreduction Cut‐off test‐positivity: prediction of complete absence of disease after cytoreduction Complications of index test: trocar metastasis 2 cases (6%), intraoperative complication 1 (3%) |
||
Target condition and reference standard(s) | Target condition: possibility of leaving no macroscopic disease at debulking surgery Criteria for target condition: extensive peritoneal carcinomatosis/involvement of bowel mesentery/bulky disease diaphragm/ multiple liver metastases/heavily bleeding tumoral tissue Reference standard: Laparotomy.Test operators: gynaecological oncologist Percentage of patients reference standard performed: 61% Unresectable disease at laparotomy: 2 |
||
Flow and timing | Time between reference standard and Index test: 0 day. | ||
Comparative | |||
Notes | 87 patients had a laparoscopy, 53 where indicated to be operable. Of these 51 had operable disease at laparotomy and 2 not. The other 34 patients were treated with NACT and 25 received an interval debulking surgery after 3 courses of chemotherapy. | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Yes | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Were the patients suspected of advanced ovarian cancer by conventional diagnostic work‐up? | Yes | ||
Were patients planned for primary cytoreductive surgery after conventional diagnostic work‐up? | Yes | ||
Low | |||
DOMAIN 2: Index Test Diagnostic open laparoscopy | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | No | ||
Were the same clinical data available when test results were interpreted as would be available when the test is used in practice? | No | ||
Did the study provide a clear definition of what was considered to be a "positive "result for the index test? | No | ||
Low | |||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | No | ||
Low | |||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Did patients receive the same reference standard regardless of the index test result? | No | ||